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emphysema score in all patients was 25.6  8 25.4%. There 
was a weak but significant correlation between the percent-
age of pulmonary emphysema and numbers of pack/years 
(R = +0.31, p = 0.024). The percentage of emphysema was 
inversely correlated with the FEV 1 /FVC ratio before and after 
bronchodilator use (R = –0.44, p = 0.002, and R = –0.39, p = 
0.005), DL CO % (R = –0.64, p = 0.0003) and DL CO /VA% (R = 
–0.68, p  ! 0.0001). A weak positive correlation was also found 
with TLC% (R = +0.28, p = 0.048). When patients with docu-
mented emphysema were considered separately, the best 
significant correlation observed was between DL CO /VA% 
and HRCT scan score (p = 0.007).  Conclusions: These data 
suggest that in patients with stable chronic obstructive pul-
monary disease of varying severity, the presence of pulmo-
nary emphysema is best represented by the impaired gas 
exchange capability of the respiratory system. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Chronic obstructive pulmonary disease (COPD) is 
an illness characterized by progressive chronic airflow 
limitation, not fully reversible  [1] . This airflow limita-
tion is usually progressive and associated with an abnor-
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 Abstract 
 Background: The literature shows conflicting results when 
high-resolution computed tomography (HRCT) scores of 
emphysema were correlated with different indices of airflow 
obstruction.  Objectives: We correlated HRCT scores of em-
physema with different indices of airflow obstruction.  Meth-
ods: We performed HRCT of the chest in 59 patients, all 
smokers or ex-smokers, with stable chronic obstructive pul-
monary disease of different severity [GOLD stages I–IV; mean 
age  8 SD 67.8  8 7.3 years; pack/years 51.0  8 34.6; percent 
predicted forced expiratory volume in 1 s (FEV 1 % predicted) 
52.3  8 17.6; post-bronchodilator FEV 1 % predicted 56.5 8 
19.1; FEV 1 /forced vital capacity (FVC) ratio 50.8  8 10.2; post-
bronchodilator FEV 1 /FVC ratio 51.6  8 11.0; percent diffusion 
lung capacity for carbon monoxide (DL CO %) 59.2  8 21.1; 
DL CO /percent alveolar volume (VA%) 54.5  8 18.2; percent 
residual volume 163.0  8 35.6; percent total lung capacity 
(TLC%) 113.2  8 15; residual volume/TLC 1.44  8 0.2]. All pa-
tients were in stable phase.  Results: The mean  8 SD visual 
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mal inflammatory response of the lung to noxious par-
ticles.
 Pathological changes characteristic of COPD are 
found in the central and peripheral airways, lung paren-
chyma and pulmonary vasculature  [2, 3] . Chronic air-
flow limitation is attributed to the narrowing of the small 
airway lumen due to morphological changes and a de-
crease in lung elastic recoil due to parenchyma destruc-
tion. Emphysema is a pathological diagnosis defined by 
permanent enlargement of airspaces distal to the termi-
nal bronchioles accompanied by the destruction of alveo-
lar walls and without obvious fibrosis. High-resolution 
computed tomography (HRCT) has a good correlation 
with the pathologic evaluation of emphysema ex vivo 
(R  1 0.9) and in vivo (R = 0.7–0.9)  [4, 5] .
 HRCT can be considered a sensitive technique for de-
tecting and quantifying pulmonary emphysema in clini-
cal practice  [6] . There is a correlation between the patho-
logic grade of emphysema on resected lung specimens and 
the preoperative CT score  [7] . A CT scan has been shown 
to be useful to assess the presence, extent and types of em-
physema. Quantitative CT has already been used in pa-
tient selection for surgical treatment of pulmonary em-
physema and in pharmacological trials  [1, 8, 9] . However, 
the use of HRCT to assess pulmonary emphysema in 
COPD has some limitations, e.g., lack of reproducibility, 
disagreements on the best method to analyze the lung pa-
renchyma, patients’ radiation exposure and the difficulty 
to obtain it in some centers, making this technique not 
suitable for follow-up  [8] . Moreover, longitudinal studies 
with an adequate sample size are lacking  [10–12] . Nonin-
vasive pulmonary measurement is easy to obtain, stan-
dardized, safe for the patient, reproducible and suitable 
for follow-up but it is less sensitive than HRCT in detect-
ing disease progression  [13, 14] . Correlation studies be-
tween HRCT evaluation of emphysema and specific mea-
sures of pulmonary function have yielded conflicting re-
sults  [6, 15–17] . A correlation has been reported between 
the HRCT-evaluated extent of emphysema and forced ex-
piratory volume in 1 s (FEV 1 ), total lung capacity (TLC), 
functional residual capacity, residual volume (RV), diffu-
sion lung capacity for carbon monoxide (DL CO ), DL CO /
alveolar volume (VA) ratio and bronchodilator-induced 
change in FEV 1 /forced vital capacity (FVC) ratio. How-
ever, the presence and extent of these correlations is con-
flicting across different studies  [6, 15–17] , making it dif-
ficult to select the best functional indices which may in-
dicate the degree of pulmonary emphysema, as evaluated 
by HRCT scan, the method of choice. The aim of the pres-
ent study was to examine the capability of a set of nonin-
vasive pulmonary measures to assess the severity of em-
physema in well-selected stable COPD patients, with a 
wide range of bronchial obstruction, by performing a 
multivariate analysis between HRCT-evaluated emphy-
sema and these pulmonary function measures.
 Subjects and Methods 
 Subjects 
 In this study, we enrolled 59 subjects (53 males and 6 females) 
affected by COPD  [1] .  Table 1 shows the patients’ demographic 
characteristics. The severity of the airflow obstruction was staged 
using current GOLD criteria  [1] . COPD was defined according to 
international guidelines, as follows: COPD = presence of a post-
bronchodilator FEV 1 /FVC ratio  ! 70%  [1] . All patients were cur-
rent or former smokers. All were in a stable clinical condition and 
had not experienced respiratory exacerbations in the previous 4 
weeks. None of the subjects were treated with theophylline, anti-
biotics, antioxidants, mucolytics and/or glucocorticoids in the 
month prior to the execution of pulmonary function tests. Only 
bronchodilator use was allowed up to 24 h before performance of 
the pulmonary function tests. The study was approved by the lo-
cal ethical committee and informed consent was obtained from 
all subjects.
 Pulmonary Function 
 A complete lung function test was carried out before and 30 
min after inhalation of 200   g of salbutamol using the Vmax 22 
system (Sensor Medics Corporation, Yorba Lynda, Calif., USA). 
At baseline and after salbutamol administration, FVC and FEV 1 
were measured according to the American Thoracic Society 
Table 1.  Patient characteristics (n = 59)
Characteristic Mean 8 SD
Age, years 67.8887.34
Pack/years 51.03834.61
Pre-bronchodilator FEV1% 52.31817.69
Post-bronchodilator FEV1% 56.55819.11
Pre-bronchodilator FEV1/FVC% 50.82810.25
Post-bronchodilator FEV1/FVC% 51.61811.07
Pre-bronchodilator FVC% 80.51820.06
Post-bronchodilator FVC% 85.09819.98
DLCO% 59.23821.15
DLCO/VA% 54.54818.22
PaO2, mm Hg 68.03812.04
PaCO2, mm Hg 42.1788.34
pH 7.4280.02
RV% 163.03835.64
TLC% 113.2815.46
RV/TLC% 1.4480.21
Emphysema, % 25.62825.39
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guidelines  [18] . Thoracic gas volume (TGV) was measured by 
body plethysmography, with the subjects panting against a closed 
shutter at a frequency slightly  ! 1 Hz with their cheeks supported 
by their hands. TLC was obtained as the sum of TGV and linked 
inspiratory capacity. RV was the difference between TLC and a 
relaxed vital capacity. Functional residual capacity was obtained 
from TGV values that were corrected for any difference between 
the volume at which the shutter was closed and the average end-
expiratory volume of the four preceding regular tidal breaths. 
Predicted values for spirometry and lung volumes were measured 
according to Quanjer et al.  [19] . DL CO and VA were measured at 
least in duplicate, as described by Huang and Macintyre  [20] . Pre-
dicted values were derived from Cotes et al.  [21] .
 HRCT Imaging 
 Chest HRCT scans were performed in the supine position with 
the breath held at full inspiration. HRCT images were selected at 
three levels including the aortic arch, carina and 1–2 cm above the 
highest hemidiaphragm.
 A General Electric Lightspeed 16 Plus CT scanner was used. 
The quantitative evaluation of emphysema was obtained by vi-
sual score technique  [22] modified by Zompatori et al.  [23] . The 
CT scan was performed using 140 kV, 200 mA, 1 s scanning time 
and 1.25 thickness, a window level between –500 and –700 
Hounsfield unit, and a window width between 1,000 and 2,000
Hounsfield unit. Emphysema was identified as areas of hypovas-
cular low attenuation and was also graded with a 5-point scale 
based on the percentage of lung involved: 0 = no emphysema, 1 = 
up to 25% of lung parenchyma involved, 2 = 26–50%, 3 = 51–75%, 
and 4 = 76–100% of lung parenchyma involved  [24] .
 Data Analysis 
 Group data were expressed as the mean  8 standard deviation 
for functional data. Correlation coefficients were calculated using 
the Spearman rank method. Multiple regression analysis was per-
formed for selected functional parameters which presented the 
best R and p values at the preliminary determination by the Spear-
man rank method. Probability values of p  ^  0.05 were considered 
significant. Data analysis was performed using the StatView SE 
Graphics program (Abacus Concepts Inc., Berkeley, Calif., USA).
 Results 
 All 59 subjects were smokers or former smokers (mean 
pack/years 51  8 34). The mean age was 67.88  8 7.36 
years. All patients were in stable clinical conditions, as 
assessed by an arterial pH  1 7.35. Twenty-four patients 
had severe or very severe obstruction (GOLD III–IV) and 
35 patients had a mild-to-moderate obstruction (GOLD 
I–II) not reversible after administration of salbutamol 
( table 1 ).  Table 1 shows the patients’ lung function char-
acteristics. The mean extent of emphysema determined 
by HRCT scan was 25.65  8 25.39%. Statistically signifi-
cant correlations were observed between percentage of 
emphysema and pack/years (R = 0.31, p = 0.02;  fig. 1 a), 
TLC (R = 0.28, p = 0.048;  fig.  1 b), pre-bronchodilator 
FEV 1 /FVC% (R = –0.44, p = 0.002;  fig. 1 c), post-broncho-
dilator FEV 1 /FVC% (R = –0.39, p = 0.005;  fig. 1 d), DL CO % 
(R = –0.64, p = 0.0003;  fig. 1 e), and DL CO /VA (R = –0.68, 
p  ! 0.0001;  fig. 1 f). When the percentage of emphysema 
was considered as a dependent variable, multivariate 
analysis showed a significant inter-relationship with pre-
bronchodilator FEV 1 /FVC% and DL CO /VA%, considered 
as independent variables (p = 0.011 and p  ! 0.0001, re-
spectively;  fig. 2 ). No correlation was found between the 
GOLD stages of COPD and the severity of emphysema. 
In all patients, our quantitative visual score of emphy-
sema was highly and significantly correlated with the 
NETT Research Group subjective visual grading score 
 [24] (R = 0.962, p  ! 0.0001). When the analysis was re-
stricted to the 33 patients with documented emphysema 
( 1 10% HRCT scan score), DL CO /VA% was the functional 
parameter, of those we studied, most significantly associ-
ated with the percentage of emphysema (R = –0.576, p = 
0.010;  fig.  3 a). A weaker correlation was observed be-
tween the percentage of emphysema and DL CO % (R = 
–0.541, p = 0.016). Multiple regression analysis, per-
formed with the two most sensitive parameters, pre-
bronchodilator FEV 1 /FVC% and DL CO /VA%, confirmed 
the association between DL CO /VA% and the scored em-
physema as the most significant (R = 0.632, intercept, p = 
0.0001; pre-bronchodilator FEV 1 /FVC%, p = 0.275; 
DL CO /VA%, p = 0.007; fig. 3 b). A weaker correlation was 
observed between DL CO % and the scored emphysema 
(R = 0.620, intercept, p = 0.0001; pre-bronchodilator 
FEV 1 /FVC%, p = 0.135; DL CO %, p = 0.011).
 Discussion 
 In this study, HRCT-evaluated emphysema correlated 
at univariate analysis with the numbers of pack/years, 
TLC, pre- and post-bronchodilator FEV 1 /FVC values, 
DL CO and DL CO /VA, and at multivariate analysis with 
pre-bronchodilator FEV 1 /FVC, DL CO and DL CO /VA. We 
developed a multivariate analysis including the percent-
age of emphysema as dependent variable, and pre-bron-
chodilator FEV 1 /FVC%, DL CO % and DL CO /VA% mea-
sures as independent variables, since these parameters of 
respiratory function are easy to obtain, safe, standardized 
and suitable for follow-up monitoring of COPD patients. 
The two dependent variables, FEV 1 /FVC% and DL CO /
VA%, were the best functional parameters associated to 
the variations of percentage of emphysema, as evaluated 
by the preliminary single regression analysis ( fig. 1 ). In 
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 Fig. 1. Regression analysis showing a significant positive correlation between the percentage of emphysema, 
evaluated by HRCT scan score, and the number of pack/years smoked ( a ) and TLC ( b ). A negative significant 
association was observed between the percentage of emphysema and pre-bronchodilator (pre) FEV 1 /FVC% ( c ), 
post-bronchodilator (post) FEV 1 /FVC% ( d ), DL CO % values ( e ), and DL CO /VA% values ( f ). 
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 Fig. 2. Multiple regression analysis, performed in all COPD pa-
tients, considering FEV 1 /FVC% and DL CO /VA% as independent 
variables and the degree of emphysema as dependent variable. 
This multiple regression shows a significant association of both 
pre-bronchodilator (pre) FEV 1 /FVC% and DL CO /VA% with the 
degree of emphysema, as measured by HRCT scan score. 
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COPD patients with  1 10% HRCT scan score.  a Simple regression 
analysis, including the percentage of emphysema and the DL CO /
VA%, shows a significant inverse association between the percent-
age of emphysema and DL CO /VA% values.  b Multiple regression 
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DL CO /VA% values as independent variables, shows a significant 
association between DL CO /VA% values and the degree of emphy-
sema, as measured by HRCT scan score. 
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addition, as an original contribution, in a subgroup of 
patients with predominant emphysema ( 1 10% HRCT 
scan score), the multivariate analysis showed the best
correlation between HRCT scan-scored emphysema and 
DL CO /VA. This study helps to clarify which measures of 
pulmonary function can assess the extent of emphysema 
and which ones correlate best with HRCT scan results.
 In agreement with previous studies  [16, 17] , we found 
that the extent of emphysema correlated inversely with 
pre- and post-bronchodilator FEV 1 /FVC and directly 
with TLC. Furthermore, correlation between CT-evalu-
ated emphysema and DL CO or DL CO /VA has also been 
documented by other authors  [25–27] .
 We here observed a statistically significant correla-
tion between HRCT-scored emphysema and number of 
pack/years smoked. These findings are in agreement 
with a larger study by Silverman and colleagues  [28] that 
found a significant relationship between pack/years 
smoked and emphysema in a large group of COPD pa-
tients and siblings recruited, suggesting the presence of 
similar selection criteria adopted in our and Silverman’s 
study.
 In our study, multivariate analysis of pre-bronchodi-
lator FEV 1 /FVC and DL CO /VA correlated significantly 
with the percentage of emphysema. When our sample 
was split and patients with  1 10% of emphysema as esti-
mated by the HRCT score were analyzed, DL CO /VA was 
more predictive of emphysema. A weaker association, al-
beit significant, was observed between DL CO % and the 
percentage of emphysema at both univariate and multi-
variate analysis. In fact, in emphysema, for a unitary VA, 
the alveolar-capillary surface area results showed a re-
duction proportionally to the extent of the emphysema-
tous lesions. This can explain why DL CO /VA better re-
flects structural abnormalities at the alveolar level in pa-
tients with various degrees of emphysema  [24, 26, 27] . 
These data suggest that, when monitoring COPD patients 
with emphysema, it is essential to include measurements 
of DL CO /VA% in the follow-up evaluation of this sub-
group of COPD patients.
 The HRCT evaluation of emphysema is at this mo-
ment the noninvasive method that best assesses the se-
verity, extent and progression of emphysema in clinical 
practice. However, the technique is limited by several 
factors, and above all, is not suitable for monitoring the 
disease progression in patients with emphysema on ac-
count of the risk of radiation exposure, particularly in 
patients with a life expectancy  1 10 years  [13] . Moreover, 
conflicting findings have been reported in the literature 
when different methods of evaluation of emphysema are 
compared  [29–31] . We used a subjective method for the 
estimation of emphysema, i.e. visual score  [22] . It has 
been reported that the analysis of visual scoring may 
lead to a systematic overestimation of emphysema  [32, 
33] . However, the majority of studies have shown reason-
ably good correlations between CT emphysema scores 
and pathological specimen, a good agreement between 
expert readers for the assessment of the presence and 
extent of emphysema, and good correlations between 
subjective and objective assessment of emphysema  [17] . 
Using 5- and 7-mm collimation with a pitch of 1.5, Park 
et al.  [17] found good correlation between 3D assessment 
of both mean lung attenuation values and frequency dis-
tribution histograms of the whole lung compared with 
routine 2D analysis (r = 0.98–0.99) and visual scoring 
(r = 0.74–0.82). Visual and automated approaches to CT 
quantification of emphysema are imperfect. The ab-
sence of a readily available gold standard (i.e. morpho-
metric estimation of emphysema extent) against which 
to compare CT quantification is a limitation in this field. 
Desai et al.  [34] showed a better correlation between a 
composite physiologic index of two physiologic variables 
[FEV 1 and percent predicted VA (carbon monoxide 
transfer coefficient)] and the extent of visually estimated 
emphysema than with the automated scoring. Moreov-
er, the authors found a strong correlation between the 
emphysema estimated visually and that quantified by 
automated scoring. They claimed that the discrepancy 
between the two methods, visual and automated, in es-
timating the extent of emphysema, is due to an under-
scoring by automated techniques rather than to over-
scoring on the part of visual estimation  [34] . On this 
basis, we are confident that our visual score technique, 
performed by a well-trained operator, well represents the 
degree of emphysema in our sample of patients with 
COPD.
 The correlation reported in the literature between the 
CT emphysema score and the pathological grade of em-
physema is very high (r = 0.91)  [32, 33, 35] . This correla-
tion in in vivo measurements is reduced, ranging from 
0.7 to 0.9. Some authors have observed that very mild em-
physema could be missed in in vivo measurements. This 
may explain why a substantial number of patients in our 
present study with considerable smoking history, proba-
bly suffering from very mild emphysema, did not show 
detectable emphysema on HRCT  [32–38] .
 In conclusion, as documented in the present study, 
lung function tests have some limitations as regards the 
measurements of airway obstruction and lung dysfunc-
tion, particularly in patients with predominant pulmo-
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nary emphysema. The development, as we here propose, 
of a multiple regression model or the use of well-selected 
and appropriate lung function measurements, may be 
helpful to give an estimate of the extent of emphysema in 
the follow-up monitoring of patients with COPD.
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